submit news    HOME | FEEDBACK  


« NAVIGATION »
NEWS

- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials

- MEMS

- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software
COMPANIES
EVENTS

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events
FEEDBACK
ADVERTISE
LINK TO US

« PARTNERS »
Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here
« NEWSLETTER »



« SEARCH »







5/27/2007 10:26:06 AM
Nanoparticles Delivery of "Suicide DNA" Kills Prostate Tumors

Using nanoparticles developed by members of the Alliance for Nanotechnology in Cancer, a team of investigators at the Lankenau Institute for Medical Research, in Philadelphia, has developed a DNA-based therapeutic agent that has the potential to treat both enlarged prostates and localized prostate tumors. When tested in mice, this new agent specifically targeted prostate tissue, producing no toxic effects in surrounding tissues.

Writing in the journal The Prostate, a team of investigators led by Janet Sawicki, Ph.D., described its use of polymer nanoparticles to delivery a so-called suicide gene that codes for the production of diphtheria toxin. The biodegradable and biocompatible polymer nanoparticles were developed by Robert Langer, Ph.D., and his colleagues at the MIT-Harvard Center of Cancer Nanotechnology Excellence.

To make their suicide gene specific for prostate tissue, the investigators linked it to a gene regulator that responds only in the presence of a prostate-specific protein. Without this protein, the diphtheria toxin gene remains inactive, which makes it nontoxic to any cells but those in the prostate.

When injected directly into the prostate, this nanoparticle-encapsulated gene construct triggered a significant reduction in the size of the prostate gland and on the size of prostate tumors. The investigators showed that this shrinkage resulted from cells undergoing apoptosis, or programmed cell death. In fact, the researchers found that a single injection of nanoparticles triggered apoptosis in 80 percent of tumor cells present in the tissue. In contrast, direct injection of the gene construct alone, that is, without the nanoparticle delivery vehicle, produced no effect on prostate tissue or tumors.

The investigators note that they expect that multiple nanoparticle injections would trigger a greater percentage of prostate tumor cells to undergo apoptosis. They are now testing this hypothesis.

This work is detailed in the paper "Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors." An investigator from the Harvard Medical School also participated in this study. An abstract of this paper is available through PubMed.

View abstract

Other Headlines from Harvard University ...
 - Engineers create vibrant colors in vertical silicon nanowires
 - Hand-held NMR Instrument Yields Rapid Analysis of Human Tumors
 - Oxford Nanopore announces licence agreement with Harvard University for graphene DNA sequencing
 - What ultra-tiny nanocircuits can do
 - Clay-armored bubbles may have formed first protocells

Other Headlines from Massachusetts Institute of Technology ...
 - Toward faster transistors
 - New sensor developed by MIT chemical engineers can detect tiny traces of explosives
 - Catching cancer with carbon nanotubes
 - Seeing below the surface
 - Koch Institute for Integrative Cancer Research dedicated at MIT

Other Headlines from NCI Alliance for Nanotechnology in Cancer ...
 - Tekmira and the National Cancer Institute Publish Promising Data Demonstrating the Anti-Tumor Activity of a Novel Cancer Target
 - NCI Awards $1.7 Million to Cancer Specialist at Children’s Hospital Los Angeles
 - Nanoparticles Enhance Detection of Circulating Tumor Cells
 - Hand-held NMR Instrument Yields Rapid Analysis of Human Tumors
 - Biodegradable Biopolymer Nanoparticles Hold Promise for Twin Attack on Breast Cancer

More Nanoparticles Headlines ...
 - UI study: Carbon black nanoparticles activate immune cells, causing cell death
 - Nanoparticles help scientists harvest light with solar fuels
 - Non-toxic nanoparticles may someday be used to fight cancer
 - 'DNAsomes' can deliver multiple drugs or genetic therapy
 - Building From the Ground Up, Researchers Construct RNA Nanoparticles to Safely Deliver Long-Lasting Therapy to Cells


« Back To List »

« GET LISTED »
- submit company
- submit news
- submit events
- advertise here

« EVENTS »
- More Events


Copyright © 2014 Nanotechwire.com | Privacy Policy |